लोड हो रहा है...
Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer
Purpose: Describe the use of osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, as the first-line treatment in a patient with choroidal and central nervous system metastases from EGFR-mutated non-small cell lung cancer. Observations: A 68-year-old man...
में बचाया:
मुख्य लेखकों: | , , , |
---|---|
स्वरूप: | Artigo |
भाषा: | Inglês |
प्रकाशित: |
Elsevier
2022-06-01
|
श्रृंखला: | American Journal of Ophthalmology Case Reports |
विषय: | |
ऑनलाइन पहुंच: | http://www.sciencedirect.com/science/article/pii/S2451993622002055 |
टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|